Danny Gabbidon

Danny Gabbidon

Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on the back of its HIV portfolio and new drug launches.
  • Trump administration appeals court order restricting immigration raids in California, raising concerns over enforcement and constitutional protections.
  • Jaguars weigh versatile rookie Travis Hunter's impact on both offense and defense as they aim to return to the playoffs.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on the back of its HIV portfolio and new drug launches.
  • Trump administration appeals court order restricting immigration raids in California, raising concerns over enforcement and constitutional protections.
  • Jaguars weigh versatile rookie Travis Hunter's impact on both offense and defense as they aim to return to the playoffs.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Danny Gabbidon